“Lack of Placental Transfer of Certolizumab Pegol During Pregnancy: Results from CRIB, a Prospective, Postmarketing, Multicenter, Pharmacokinetic Study”, J of Skin, vol. 1, no. 3.1, p. s21, Oct. 2017, doi: 10.25251/skin.1.supp.20.